| Primary |
| Tuberculosis |
66.7% |
| Product Used For Unknown Indication |
33.3% |
|
| Hepatocellular Injury |
100.0% |
|
| Secondary |
| Tuberculosis |
30.7% |
| Hiv Infection |
15.5% |
| Pulmonary Tuberculosis |
10.7% |
| Disseminated Tuberculosis |
10.2% |
| Drug Use For Unknown Indication |
4.8% |
| Acquired Immunodeficiency Syndrome |
4.0% |
| Lymph Node Tuberculosis |
3.2% |
| Meningitis Tuberculous |
3.2% |
| Toxoplasmosis |
2.4% |
| Insomnia |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Antifungal Prophylaxis |
1.6% |
| Epilepsy |
1.6% |
| Prophylaxis |
1.6% |
| Meningitis |
1.3% |
| Antibiotic Therapy |
1.1% |
| Immune Reconstitution Syndrome |
1.1% |
| Pyrexia |
1.1% |
| Antiretroviral Therapy |
0.8% |
| Hypertension |
0.8% |
|
| Hepatitis Fulminant |
9.6% |
| Urticaria |
9.6% |
| Vomiting |
9.6% |
| Tuberculosis Liver |
7.7% |
| Vertigo |
7.7% |
| Immune Reconstitution Syndrome |
5.8% |
| Nervous System Disorder |
5.8% |
| Rash |
5.8% |
| Renal Tubular Disorder |
5.8% |
| Hepatic Enzyme Increased |
3.8% |
| Hepatocellular Damage |
3.8% |
| Jaundice |
3.8% |
| Multi-organ Failure |
3.8% |
| Rash Maculo-papular |
3.8% |
| Renal Failure Acute |
3.8% |
| Cytolytic Hepatitis |
1.9% |
| Depression |
1.9% |
| Grand Mal Convulsion |
1.9% |
| Hepatitis Cholestatic |
1.9% |
| Hepatocellular Injury |
1.9% |
|
| Concomitant |
| Tuberculosis |
31.7% |
| Hiv Infection |
22.2% |
| Pulmonary Tuberculosis |
15.3% |
| Drug Use For Unknown Indication |
6.8% |
| Prophylaxis |
5.6% |
| Antifungal Prophylaxis |
3.1% |
| Disseminated Tuberculosis |
2.2% |
| Pain |
1.7% |
| Atypical Mycobacterial Infection |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Anaemia |
1.3% |
| Cytomegalovirus Infection |
1.3% |
| Acquired Immunodeficiency Syndrome |
0.8% |
| B-cell Lymphoma |
0.8% |
| Diarrhoea |
0.8% |
| Hypertension |
0.8% |
| Pericarditis |
0.8% |
| Peritoneal Tuberculosis |
0.8% |
| Mycobacterium Avium Complex Infection |
0.7% |
| Influenza |
0.6% |
|
| Pyrexia |
22.4% |
| Renal Failure |
10.6% |
| Tuberculosis |
9.4% |
| Vomiting |
9.4% |
| Renal Failure Acute |
4.7% |
| Electroencephalogram Abnormal |
3.5% |
| Hepatic Failure |
3.5% |
| Impaired Gastric Emptying |
3.5% |
| Lymphadenopathy |
3.5% |
| Rash Maculo-papular |
3.5% |
| Rash Pruritic |
3.5% |
| Sputum Purulent |
3.5% |
| Drug Level Below Therapeutic |
2.4% |
| Optic Neuritis Retrobulbar |
2.4% |
| Renal Failure Chronic |
2.4% |
| Skin Lesion |
2.4% |
| Splenomegaly |
2.4% |
| Tachycardia |
2.4% |
| Tendon Rupture |
2.4% |
| Toxic Skin Eruption |
2.4% |
|
